Attached files
file | filename |
---|---|
10-K - ONCOVISTA INNOVATIVE THERAPIES, INC | v179464_10k.htm |
EX-31.1 - ONCOVISTA INNOVATIVE THERAPIES, INC | v179464_ex31-1.htm |
EX-31.2 - ONCOVISTA INNOVATIVE THERAPIES, INC | v179464_ex31-2.htm |
Exhibit
32
CERTIFICATIONS
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of OncoVista Innovative Therapies, Inc. (the
Company”) on Form 10-K for the period ending December 31, 2009 as filed with the
Securities and Exchange Commission on the date hereof, I, Alexander L. Weis,
Chief Executive Officer and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley
Act of 2002, that:
1. The
report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
2. The
information contained in the report fairly presents, in all material respects,
the financial condition and result of operations of the Company.
Date: March
31, 2010
/s/ Alexander L. Weis | |
Alexander
L. Weis, Ph.D.,
|
|
Chief
Executive Officer and
|
|
Chief
Financial Officer
|